VIGL(Delisted)
Vigil Neuroscience (VIGL) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Vigil Neuroscience market cap is -- and enterprise value is --.
Share Statistics
Vigil Neuroscience has 47.70M shares outstanding, with a free float of 31.96M.
Valuation Ratios
Vigil Neuroscience's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Vigil Neuroscience debt-to-equity ratio is -- and debt-to-assets ratio is 0.52.
Liquidity
Vigil Neuroscience's current ratio is 2.06, quick ratio is 2.06, and cash ratio is --, showing its short-term liquidity position.
Return on Capital
Vigil Neuroscience's ROE is --, ROA is --, and ROIC is --, showing its return on capital profile.
Profitability
Vigil Neuroscience gross margin is --, operating margin is --, and net margin is --.
Operating Efficiency
Vigil Neuroscience's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
Vigil Neuroscience's revenue is --, gross profit is --, net income is --, and EBITDA is --.
Balance Sheet
Vigil Neuroscience's total debt is --, net debt is --, total equity is --, and cash is --.
Cash Flow Statement
Vigil Neuroscience's operating cash flow is -58.21M, free cash flow is -58.57M, and CapEx is -354.00K.
Dividends & Yields
Vigil Neuroscience dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Vigil Neuroscience's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A microglia-focused therapeutics company focused on developing treatments for neurodegenerative diseases
Per Share Metrics
Vigil Neuroscience's EPS is --, book value per share is --, and free cash flow per share is --.
